Cardio-vascular Activity of Catestatin: Interlocking the Puzzle Pieces
Journal:
Current Medicinal Chemistry
Volume:
22
Page:
292-304
Author(s):
R. Mazza, B. Tota and A. Gattuso
New Antihypertensive Drugs Under Development
Journal:
Current Medicinal Chemistry
Volume:
22
Page:
305-342
Author(s):
J. Tamargo, J. Duarte and L.M. Ruilope
Asymptomatic Lone Atrial Fibrillation - How can we Detect the Arrhythmia?
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
659-666
Author(s):
Giuseppe Boriani, Cinzia Valzania, Mauro Biffi, Igor Diemberger, Matteo Ziacchi and Cristian Martignani
Biomarkers in Lone Atrial Fibrillation-An Additional ‘Fine Tuning’ of Risk?
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
646-658
Author(s):
Darae Ko, Jared W. Magnani and Elaine M. Hylek
The Heart and Brain Imaging in Lone Atrial Fibrillation – Are We Surprised?
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
613-621
Author(s):
Eduard Shantsila, Karl Georg Haeusler, Jochen B. Fiebach, Gunter Breithardt and Paulus Kirchhof
Lone Atrial Fibrillation: Electrophysiology, Risk Factors, Catheter Ablation and Other Non-pharmacologic Treatments
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
580-590
Author(s):
Arun Kanmanthareddy, Martin P. Emert, Rhea C. Pimentel, Yeruva Madhu Reddy, Sudharani Bommana, Donita Atkins, Rachana Tadakamalla, Thanmay Lakkireddy and Dhanunjaya Lakkireddy
Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
551-572
Author(s):
B. Weijs, U. Schotten and H.J.G.M. Crijns
Utility of Anti-Arrhythmic Medications in ‘Lone Atrial Fibrillation’
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
573-579
Author(s):
Ramanan Kumareswaran and Paul Dorian
A Brief History of ‘Lone’ Atrial Fibrillation: From ‘A Peculiar Pulse Irregularity’ to a Modern Public Health Concern
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
679-696
Author(s):
Tatjana S. Potpara and Gregory Y.H. Lip
Genetic Aspects of Lone Atrial Fibrillation: What Do We Know?
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
667-678
Author(s):
Laura Andreasen, Jonas B. Nielsen and Morten S. Olesen